STOCK TITAN

ALX Oncology Holdings Inc. (ALXO) Debt by Year

ALXO

ALX Oncology Holdings Inc. carried $4.5M in long-term debt against $16.4M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 52.1% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters ALX Oncology Holdings Inc. has filed alongside them.

FY2025 annual
Long-Term Debt $4.5M
Cash & Equivalents $16.4M
YoY -52.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ALXO Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Long-Term Debt$4.5M-52.1%$9.5M-1.8%$9.6M+2.7%$9.4MN/AN/A$5.4MN/A
Cash & Equivalents$16.4M-6.8%$17.6M-21.6%$22.4M-54.1%$48.8M-86.6%$363.7M-16.2%$434.2M+4715.6%$9.0M+9.1%$8.3M

ALXO Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term Debt$9.7M+38.7%$3.3M-60.0%$4.5M-52.1%$5.8M-41.4%$7.0M-28.4%$8.2M-15.2%$9.5M-1.8%$9.8M+2.7%$9.8M+2.7%$9.7M+2.7%$9.6M+2.7%$9.6M
Cash & Equivalents$22.7M+17.5%$32.3M+56.6%$16.4M-6.8%$23.4M+45.6%$19.3M+24.3%$20.6M+46.8%$17.6M-21.6%$16.1M-17.8%$15.5M-59.2%$14.0M-77.8%$22.4M-54.1%$19.6M-60.1%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More ALX Oncology Holdings Inc. financials

Frequently Asked Questions

What was ALX Oncology Holdings Inc.'s long-term debt in fiscal year 2025?

ALX Oncology Holdings Inc. carried $4.5M in long-term debt against $16.4M in cash and equivalents at the end of fiscal year 2025.

How fast is ALX Oncology Holdings Inc.'s long-term debt growing?

ALX Oncology Holdings Inc. (ALXO) long-term debt fell by 52.1% year over year, from $9.5M to $4.5M in fiscal year 2025.

What was ALX Oncology Holdings Inc.'s long-term debt in the most recent quarter?

ALX Oncology Holdings Inc. (ALXO) reported $9.7M in long-term debt in Q2 2026. This represents an increase of 38.7% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what ALX Oncology Holdings Inc. (ALXO) reported on that line in every period on record.